DSM-Firmenich AG
DSFIR.XAMS
DSM-Firmenich AG is a science-driven specialty chemicals company focused on nutrition, health, and beauty solutions for global consumer and industrial markets. Headquartered in Kaiseraugst, Switzerland, the company develops and manufactures ingredients and systems that enhance the taste, texture, performance, and sustainability of end products across food, beverages, personal care, home care, and animal nutrition. Its activities are organized into four main segments: Perfumery & Beauty, Taste, Texture & Health, Health, Nutrition & Care, and Animal Nutrition & Health. These segments provide fragrances and flavors, vitamins, lipids, minerals, carotenoids, probiotics, enzymes, and other bioactive ingredients, alongside formulation and regulatory expertise for customers worldwide. DSM-Firmenich AG serves consumer goods companies, food and beverage producers, pharmaceutical and nutraceutical firms, and animal protein producers across Europe, the Americas, Asia, the Middle East, and Africa. The company positions itself as an innovator in natural and renewable ingredients, combining biotechnology, chemistry, and material science to support product differentiation and more sustainable consumer offerings.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€9.03B
▼ -0.2% YoY
Net Income (TTM)
-€1.08B
▼ -532.4% YoY
Op. Margin
7.87%
▲ +1.8pp YoY
ROIC
2.31%
▲ +0.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€817M
▼ -27.9% YoY
Op. Cash Flow (TTM)
€1.45B
▼ -18.7% YoY
Net Debt
€3.37B
Cash & Equiv.
€1.90B
3Y CAGR: +2.5%
3Y CAGR: +42.7%
Continue Research
Peers
Specialty Chemicals · Pick stocks to compare with DSFIR.XAMS
Held by ETFs
DSFIR.XAMS is in 47 US ETFs. The largest of them, with DSFIR.XAMS's weight in each:
Vanguard Total International Stock ETFVXUS0.05%of the fund
Vanguard FTSE Developed Markets ETFVEA0.06%of the fund
iShares Core MSCI EAFE ETFIEFA0.08%of the fund
Vanguard Total World Stock ETFVT0.02%of the fund
Vanguard FTSE All-World ex-US Index Fund ETF SharesVEU0.05%of the fund
iShares MSCI EAFE ETFEFA0.09%of the fund
DSM-Firmenich (DSFIR.XAMS) in four numbers
Questions about DSM-Firmenich
Is DSM-Firmenich (DSFIR.XAMS) overvalued?
At €104.15, DSM-Firmenich's price is 103% above the €51.36 a share fair value that Intrinsiqq's calculator gets from its free cash flow. It trades at 32.27 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is DSM-Firmenich's fair value?
Intrinsiqq's calculator puts DSM-Firmenich's fair value at €51.36 a share. It grows free cash flow per share 0% a year for 5 years, applies an exit P/FCF of 20.9, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of €38.52. Every input can be changed on the Intrinsic Value tab.
Is DSM-Firmenich a high-quality business?
DSM-Firmenich scores 32 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 7 checks computed from company filings. Its best check is cash flow growth at 42.7%, and its weakest is return on capital at 2.3%. The Quality tab shows every check against its target.
Does DSM-Firmenich (DSFIR.XAMS) pay a dividend, and how much?
Yes. DSM-Firmenich (DSFIR.XAMS) pays a dividend: €2.50 per share over the last twelve months, a dividend yield of 2.46% at the latest close. Its dividend per share has grown at 0.0% a year over the last 2 years. The Dividends tab has the full payment history and the safety score.
Source: company filings. Price: last close 16 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing DSFIR.XAMS
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.